Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duodopa Dyskinesia PK/PD Study
NCT00888186Phase 4Completed
- Sponsor
- Uppsala University
- Start
- Feb 2008
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levodopa + carbidopa and carbidopa in Parkinson's disease (PD) (5 arms), sponsored by Uppsala University. Primary endpoint: Correlation between plasma levodopa concentration and choreatic dyskinesia, dystonia, and parkinsonism at 3 days. Started Feb 2008; status: completed.
02
Drugs
levodopa + carbidopacarbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00888186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00888186.